Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries

dc.contributor.authorLeigh, Jeanne Parsons
dc.contributor.authorMoss, Stephana J.
dc.contributor.authorWhite, Trenton M.
dc.contributor.authorPicchio, Camila A.
dc.contributor.authorRabin, Kenneth
dc.contributor.authorRatzan, Scott
dc.contributor.authorWyka, Katarzyna
dc.contributor.authorEl-Mohandes, Ayman
dc.contributor.authorLazarus, Jeffrey V.
dc.date.accessioned2024-11-22T15:59:14Z
dc.date.available2024-11-22T15:59:14Z
dc.date.issued2022-07-29
dc.date.updated2024-11-22T15:59:14Z
dc.description.abstractBackground: Several early COVID-19 studies aimed to assess the potential acceptance of a vaccine among healthcare providers, but relatively few studies of this population have been published since the vaccines became widely available. Vaccine safety, speed of development, and low perceived disease risk were commonly cited as factors for COVID-19 vaccine hesitancy among this group. Purpose and methods: In a secondary analysis based on a cross-sectional, structured survey, the authors aimed to assess the associations between self-reported vaccine hesitancy and a number of sociodemographic and COVID-19 vaccine perception factors using data from 3,295 healthcare providers (physicians, nurses, community health workers, other healthcare providers) in 23 countries. Findings: 494 (15.0%) of the participants reported vaccine hesitancy, of whom 132 (4.0%) would outright refuse to accept a COVID-19 vaccine. Physicians were the least hesitant. Vaccine hesitancy was more likely to occur among those with less than the median income and, to a lesser degree, younger age. Safety and risk concerns and lack of trust that vaccines would be equitably distributed were strongly associated with hesitancy, less so were concerns about the efficacy of COVID-19 vaccines. Interpretation: Findings suggest a need to address safety and risk concerns through tailored messaging, training, and/or incentive approaches among healthcare providers, as well as the need for international and national vaccination efforts to ensure equitable distribution.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec751623
dc.identifier.issn0264-410X
dc.identifier.pmid35654620
dc.identifier.urihttps://hdl.handle.net/2445/216698
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.vaccine.2022.04.097
dc.relation.ispartofVaccine, 2022, vol. 40, num.31, p. 4081-4089
dc.relation.urihttps://doi.org/10.1016/j.vaccine.2022.04.097
dc.rightscc-by-nc-nd (c) Leigh, Jeanne Parsons et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationCOVID-19
dc.subject.classificationSARS-CoV-2
dc.subject.classificationVacunes
dc.subject.classificationPersonal sanitari
dc.subject.classificationPercepció del risc
dc.subject.classificationSeguretat dels productes
dc.subject.otherCOVID-19
dc.subject.otherSARS-CoV-2
dc.subject.otherVaccines
dc.subject.otherMedical personnel
dc.subject.otherRisk perception
dc.subject.otherProduct safety
dc.titleFactors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
870155.pdf
Mida:
1.11 MB
Format:
Adobe Portable Document Format